KEGG   DRUG: Enoxaparin sodiumHelp
Entry
D03674                      Drug                                   

Name
Enoxaparin sodium (JAN/USAN/INN);
Lovenox (TN)
Product
  Generic
Class
Cardiovascular agent
 DG01709  Heparin anticoagulant
 DG01950  Antithrombotic agent
  DG01709  Heparin anticoagulant
Remark
Therapeutic category: 3339
ATC code: B01AB05
Chemical structure group: DG00150
Product (DG00150): D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03337<JP> D03353<JP/US>
Efficacy
Anticoagulant, Antithrombin III activator
Comment
Sodium salt of a low-molecular weight Heparin [CPD:C00374] obtained by alkaline depolymerization of the benzyl ester of Heparin from porcine mucosa.
Low molecular weight heparin (LMWH)
Target
SERPINC1 (AT3) [HSA:462] [KO:K03911]
  Pathway
hsa04610  Complement and coagulation cascades
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B01 ANTITHROMBOTIC AGENTS
   B01A ANTITHROMBOTIC AGENTS
    B01AB Heparin group
     B01AB05 Enoxaparin
      D03674  Enoxaparin sodium (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Blood Products and Modifiers
  Anticoagulants
   Enoxaparin
    D03674  Enoxaparin sodium (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  33  Blood and body fluid agents
   333  Anticoagulants
    3339  Others
     D03674  Enoxaparin sodium (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Complement and coagulation
    SERPINC1 (AT3)
     D03674  Enoxaparin sodium (JAN/USAN/INN) <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D03674
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D03674
BRITE hierarchy
Other DBs
CAS: 679809-58-6
PubChem: 17397770
DrugBank: DB01225
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system